Kary Eldred's Insider Trades & SAST Disclosures
Kary Eldred's most recent trade in Galectin Therapeutics Inc was a trade of 60,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on Jan. 23, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Kary Eldred.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Galectin Therapeutics Inc | Kary Eldred | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2025 | 60,000 | 60,000 | - | - | Stock Option (right to buy) | |
| Galectin Therapeutics Inc | Kary Eldred | Director | Purchase of securities on an exchange or from another person at price $ 0.82 per share. | 24 Dec 2024 | 13,469 | 63,682 (0%) | 0% | 0.8 | 11,045 | Common Stock |
| Galectin Therapeutics Inc | Kary Eldred | Director | Purchase of securities on an exchange or from another person at price $ 2.60 per share. | 23 Oct 2024 | 500 | 50,213 (0%) | 0% | 2.6 | 1,300 | Common Stock |
| Galectin Therapeutics Inc | Kary Eldred | Director | Purchase of securities on an exchange or from another person at price $ 2.39 per share. | 22 Jul 2024 | 400 | 49,713 (0%) | 0% | 2.4 | 956 | Common Stock |
| Galectin Therapeutics Inc | Eldred Kary | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2024 | 50,000 | 50,000 | - | - | Stock Option (right to buy) | |
| Galectin Therapeutics Inc | Eldred Kary | Director | Purchase of securities on an exchange or from another person at price $ 1.79 per share. | 16 Jan 2024 | 500 | 49,313 (0%) | 0% | 1.8 | 893 | Common Stock |
| Galectin Therapeutics Inc | Kary Eldred | Director | Purchase of securities on an exchange or from another person at price $ 1.79 per share. | 19 Jul 2023 | 1,598 | 48,813 (0%) | 0% | 1.8 | 2,854 | Common Stock |
| Galectin Therapeutics Inc | Kary Eldred | Director | Purchase of securities on an exchange or from another person at price $ 1.59 per share. | 21 Feb 2023 | 1,000 | 47,215 (0%) | 0% | 1.6 | 1,591 | Common Stock |
| Galectin Therapeutics Inc | Kary Eldred | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2023 | 40,000 | 40,000 | - | - | Stock Option (right to buy) | |
| Galectin Therapeutics Inc | Kary Eldred | Director | Purchase of securities on an exchange or from another person at price $ 1.11 per share. | 25 Jan 2023 | 1,300 | 46,215 (0%) | 0% | 1.1 | 1,443 | Common Stock |
| Galectin Therapeutics Inc | Kary Eldred | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2022 | 40,000 | 40,000 | - | - | Stock Option (right to buy) | |
| Galectin Therapeutics Inc | Kary Eldred | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Mar 2021 | 70,000 | 70,000 | - | - | Stock option (right to buy) | |
| Galectin Therapeutics Inc | Kary Eldred | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Mar 2021 | 40,000 | 40,000 | - | - | Stock option (right to buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges